Neurogene Inc (NGNE)

Operating Cash Flow Growth

-17.65%

TTM · Period ending:

NGNE logo

NGNE Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-17.65%
NGNE TTM Cash from Operations YoY % (17.75% → -17.65%)
High-resolution chart · PNG

NGNE operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Neurogene Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-17.6548%
-17.5115%
-8.483%
6.3037%
6.78%
3.2387%
-10.3761%
-85.1285%
-87.9262%
-64.8841%
-44.5885%
3.2445%
8.114%
9.0104%
6.4671%
-2.56%
-21.9702%
-49.1015%
-86.9802%
-122.7818%
-42.0899%
-68.1485%
-13.724%
38.3217%
-55.8418%
28.2271%
-0.6253%
44.8846%
32.1227%
24.3791%
17.7537%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.